Published in Drug Week, July 2nd, 2004
People who reported high levels of carbohydrate cravings experienced significant decrease in their carbohydrate cravings and depression in response to chromium picolinate. Also, there was no difference in side effects in patients treated with chromium picolinate compared to those treated with the placebo. Atypical depression is a common, but frequently undiagnosed, form of depression affecting up to 40 million Americans.
The new evidence was presented at a...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.